Magnet Recognized 🌟 UPMC Eases Nursing Burden.
See Study
→
877-349-4582
Request A Demo
Search
Solutions
EndoTool Glucose Management System
EndoTool IV
EndoTool SubQ
Interoperability
Analytics
Professional Services
Why it Matters
Evidence
About
Company Overview
Leadership Team
Clinical Advisory Board
Newsroom
Partnerships
Careers
Resources
Blog
Contact
877-349-4582
Request A Demo
877-349-4582
Request A Demo
Blog
ADA
,
Conferences
/
Monarch Participates in American Diabetes Association Tour de Cure Fundraiser
This April, Monarch Medical Technologies will participate in the 25th annual Tour de Cure hosted by the American Diabetes Association in Charlotte, North Carolina. The Tour de Cure is a series of fundraising cycling events held in 44 states nationwide to benefit the American Diabetes Association. Monarch Medical Technologies is thrilled to be involved with the community at this year’s Tour...
ADA
Conferences
Computerized Dosing
,
EndoTool
,
Glycemic Management
/
Inpatient Glucose Management: Part 3
Glucose Management Software This blog series has been used to educate our readers on inpatient glucose management. In part 1, we explored the risks and complications, and in part 2, we explored best practices recommended by the American Diabetes Association and The Joint Commission. In this post, we will come full circle with the benefits of inpatient glucose management software....
Computerized Dosing
EndoTool
Glycemic Management
ADA
,
Glycemic Management
,
The Joint Commission
/
Inpatient Glucose Management: Part 2
ADA and Joint Commission Guidelines for Best Practices In part 1 of this series, we explained the risks and complications associated with inpatient glucose control. We learned that occurrences include hyperglycemia, hypoglycemia, poor treatment and/or lack of control, and hospital-acquired conditions. The American Diabetes Association (ADA) and The Joint Commission have created recommendations for diabetes care in the hospital. Some...
ADA
Glycemic Management
The Joint Commission
Glycemic Management
/
Inpatient Glucose Management: Part 1
Risks and Complications Risks and complications associated with inpatient glucose control spark some of the most dreaded conversations exchanged in healthcare. Clinicians are accustomed with these situations and would prefer little or no occurrence. The detrimental obstacles include: Hyperglycemia – High blood sugar in hospitalized patients is common and associated with increased risk of infection, mortality and escalated cost. Hypoglycemia...
Glycemic Management
DKA
/
Diabetic Ketoacidoisis (DKA): What You Should Know
What is DKA? Diabetic ketoacidosis, or DKA, is a serious complication of diabetes that occurs when your body produces high levels of blood acids called ketones. How does DKA occur? When the body cannot produce enough insulin, the body begins to burn fat for energy and produces a buildup of acids in the bloodstream called ketones. Once the ketones build up...
DKA
CMS
/
How a Glucose Management System is Associated with Reimbursements
Every day, the United States fights the ongoing battle regarding the cost of healthcare. Reimbursement rates are dropping and hospitals question every expense in order to find justification for new tools and treatment options. The complex issue occurs when addressing all conditions, including hyperglycemia, a significant concern that is linked to higher mortality rates. Despite the understanding that manifestations of...
CMS
EndoTool
,
Personalized Dosing
,
Residual Insulin
/
Estimated Residual Extracellular Insulin (EREI): What Is It?
Estimated residual extracellular insulin, or EREI, refers to residual insulin present in a patient’s body. Every patient receiving insulin therapy requires personalized treatment based on their individual makeup. In addition to this, each patient’s need for insulin is not only different, but, ever-changing based on activity level, meals consumed and stress. The amount of residual insulin present in a person’s...
EndoTool
Personalized Dosing
Residual Insulin
EndoTool
,
IV Insulin Dosing
/
Study Compares EndoTool to Paper Protocol in the ICU
Everything is more intense in the intensive care unit (ICU). Critically ill patients demand more frequent and detailed monitoring as well as timely and precise interventions to address their fragile state. These patients health can be impacted by a wide range of factors, including blood sugar. Statistics show that approximately 30-50% of ICU patients experience stress-induced hyperglycemia, which is typically...
EndoTool
IV Insulin Dosing
EndoTool
,
Transition IV to SubQ
/
Streamlining the Transition from IV to SubQ Insulin
Intravenous (IV) insulin infusion is a standard protocol for treating critically ill hospitalized patients with hyperglycemia. However, once glucose levels stabilize, patients may be transitioned to subcutaneous (SubQ) insulin injections. The transition from IV to SubQ dosing involves many variables and can be difficult to achieve without a few bumps along the way. While some hospitals follow standard transition protocols,...
EndoTool
Transition IV to SubQ
Glycemic Steering Committee
,
Pharmacy
,
Transition IV to SubQ
/
Is Pharmacy on Your Glucose Management Team?
When it comes to managing glucose levels in the hospital, the pharmacist can play an active role and, with broad expertise in medication management, make a unique contribution. Pharmacists are well informed of the risks associated with hyperglycemia and the benefits of tighter glycemic control, as well as the impact of the all-too-common hyperglycemia to hypoglycemia swing. If a patient...
Glycemic Steering Committee
Pharmacy
Transition IV to SubQ
Diabetes
/
Understanding and Treating Diabetes Throughout The Ages
Diabetes has plagued sufferers long before it was ever given a name and before the characteristics of diabetes were recognized. Only relatively recently has modern science shed light on the root of the disease and given new hope to patients with diabetes. As early as 1552 BC, a Greek physician identified diabetes as a disease characterized by frequent urination and...
Diabetes
ADA
,
Diabetes
/
What’s Your Diabetes IQ?
November is American Diabetes Month. What’s your diabetes IQ? How much do you really know about the disease? While EndoTool addresses the need for insulin therapy in hospitalized patients, a significant number of these patients have been previously diagnosed (or will be) with diabetes. In honor of American Diabetes Month, we thought we would take a step back and look...
ADA
Diabetes
Computerized Dosing
,
Cost Savings
,
EndoTool
/
Hospital Demonstrates LOS and Cost Benefit from Glucose Management Software
A study at United Regional Health Care System (URHCS), a major 325-bed hospital in Wichita Falls, Texas, proves that safe and efficient glucose management not only improves the delivery of insulin therapy, but decreases overall length of stay and results in financial savings for the hospital. As part of its commitment to leverage advanced medical technology for the benefit of...
Computerized Dosing
Cost Savings
EndoTool
EndoTool
,
SubQ Insulin Dosing
/
Glucose Management Software Optimizes Subcutaneous Insulin Dosing for Hospitalized Patients With Diabetes
When patients with diabetes enter the hospital, they don’t check their diabetes at the door. Managing diabetes while delivering treatment for other conditions is an added challenge for hospitalized patients where the condition may be either ongoing or a temporary abnormality. While always important, appropriate glucose management is particularly a concern for patients undergoing medical treatment — critical or not...
EndoTool
SubQ Insulin Dosing
EndoTool
,
Hypoglycemia
/
Hypoglycemia: Not to Be Overlooked
Hyperglycemia is a topic frequently discussed in hospitals today. It is not a defining characteristic of diabetes, but is a hefty threat to the body if not addressed in a timely manner. When left untreated, hyperglycemia can cause long-term complications of diabetes such as: eye damage, heart attack, kidney damage, nerve damage, and stroke. Healthcare puts a strong emphasis on...
EndoTool
Hypoglycemia
Prev
1
2
3
4
5
6
7
8
Next
Search
Submit
Clear
Tags
A1C
ADA
CMS
Computerized Dosing
Conferences
Continuous Glucose Monitoring
Cost Savings
COVID-19
Diabetes
DKA
EMR Integration
EndoTool
Gestational Diabetes
Glycemic Management
Glycemic Steering Committee
Guidelines and Standards
Heart Failure
Hyperglycemia
Hypoglycemia
Hypothermia
Insulin
IV Insulin Dosing
Nursing
Obstetrics
Patient Safety
Performance Improvement
Personalized Dosing
Pharmacy
Renal Failure
Residual Insulin
Society of Hospital Medicine
SubQ Insulin Dosing
Surgical Site Infection
The Joint Commission
Transition IV to SubQ
Trauma
Wearable Technology
Workflow
Search
Submit
Clear
Client Login
Search
Submit
Clear
Solutions
EndoTool Glucose Management System
EndoTool IV
EndoTool SubQ
Interoperability
Analytics
Professional Services
Why it Matters
Evidence
About
Company Overview
Leadership Team
Clinical Advisory Board
Newsroom
Partnerships
Careers
Resources
Blog
Contact
Case Study
Discover UPMC Central Pennsylvania's approach to a 92% reduction in hypoglycemia.
Download Case Study
Scroll Up